Reduced HMGB1 induces Beclin1-dependent autophagy and promotes tumor resistance to several chemotherapeutic agents, whereas oxidized HMGB1 induces apoptosis via the mitochondrial caspase-9/-3 pathway [15]. This evidence concerns the gene HMGB1 and neoplasm.